RE:RE:RE:RE:RE:RE:The Big Bad CMA in the UKApollo does not have an existing drug portfolio. About time they had one though:)
CLtrader1 wrote: I don't disagree. my point is the short interest pushing articles as if they are real issues has created a panic that CXR is doing something wrong. I think it is important to fully understand what we are dealing with... Shorts instill fear until longs puke.. headline articles can be scary and should be taken with context. I agree, CXR is a perfect PE candidate, especially for Apollo as there is synergies with their existing drug portfolios